Back to Search
JEFF MEYER, PHARMD
PHARMD
Pharmacist
NPI: 1083061493Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
PMID 19640511·Biol Psychiatry·2009
3-trial
The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia.
PMID 19192469·J Clin Psychiatry·2009
4-observational
Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.
PMID 18258416·Schizophr Res·2008
3-trial
Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.
PMID 18534821·Schizophr Res·2008
3-trial
Strategies for the long-term treatment of schizophrenia: real-world lessons from the CATIE trial.
PMID 17286525·J Clin Psychiatry·2007
8-other
Prevalence of the metabolic syndrome in veterans with schizophrenia.
PMID 16432440·J Psychiatr Pract·2006
4-observational
Effects of switching from olanzapine to risperidone on the prevalence of the metabolic syndrome in overweight or obese patients with schizophrenia or schizoaffective disorder: analysis of a multicenter, rater-blinded, open-label study.
PMID 16507379·Clin Ther·2005
3-trial
Lithium toxicity after switch from fosinopril to lisinopril.
PMID 15729089·Int Clin Psychopharmacol·2005
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7704 W 32ND ST
SIOUX FALLS, SD 57106 - Phone
- (605) 212-1094
Quick Facts
- NPI
- 1083061493
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile